Advertisement

Topics

Drug-Research Shake Up Continues as Pamplona Buys Parexel

05:26 EDT 20 Jun 2017 | Fox Business

Private-equity firm Pamplona Capital Management has reached a deal to buy Parexel International Corp. for $4.6 billion, the latest in a series of mergers among drug-research firms

Original Article: Drug-Research Shake Up Continues as Pamplona Buys Parexel

NEXT ARTICLE

More From BioPortfolio on "Drug-Research Shake Up Continues as Pamplona Buys Parexel"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...